Alumis (ALMS) Research & Development (2023 - 2025)
Alumis' (ALMS) quarterly Research & Development came in at $82.8 million in Q4 2025, down 5.07% year-on-year from $87.2 million in Q4 2024, and down 15.38% on a QoQ basis from $97.8 million in Q3 2025.
Alumis (ALMS) Research & Development (2023 - 2025) Analysis & Trends
Alumis (ALMS) has 3 years of Research & Development data on file, last reported at $82.8 million in Q4 2025.
- On a quarterly basis, Research & Development fell 5.07% year-over-year to $82.8 million in Q4 2025; TTM through Dec 2025 was $386.0 million, a 45.36% increase from a year earlier, with the FY2025 full-year figure at $386.0 million, up 45.36% from the prior year.
- Research & Development for Q4 2025 stood at $82.8 million, down from $97.8 million in the prior quarter.
- Over the last five years, Research & Development for ALMS reached as high as $108.8 million in Q2 2025 and fell as low as $32.8 million in Q2 2023.
- Historically, Research & Development has averaged $68.8 million across 3 years, with a median of $82.8 million in 2025.
- Across the five-year window, Research & Development soared 152.0% in 2024 and slipped 5.07% in 2025, its largest moves.
- Year by year, Research & Development stood at $34.6 million in 2023, then soared by 152.0% to $87.2 million in 2024, then declined by 5.07% to $82.8 million in 2025.
- Per Business Quant data, the three most recent Research & Development figures were $82.8 million in Q4 2025, $97.8 million in Q3 2025, and $108.8 million in Q2 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | -17.94 Mn |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | 1.46 Mn |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 541.22 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 961.60 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 1.54 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | 15.66 Mn |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -443.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 343.97 Mn |
| 10 | Alumis | 2.37 Bn | 2.06 Bn | - | 82.79 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 82.79 Mn |
| Sep 30, 2025 | 97.84 Mn |
| Jun 30, 2025 | 108.76 Mn |
| Mar 31, 2025 | 96.62 Mn |
| Dec 31, 2024 | 87.20 Mn |
| Sep 30, 2024 | 87.82 Mn |
| Jun 30, 2024 | 48.57 Mn |
| Mar 31, 2024 | 41.96 Mn |
| Dec 31, 2023 | 34.61 Mn |
| Sep 30, 2023 | 37.79 Mn |
| Jun 30, 2023 | 32.85 Mn |